Citigroup has maintained a buy rating on Aurobindo Pharma with a 12-month target price of Rs 1,170. The valuations are at 1x FY18F book which is reasonable.Deutsche Bank maintained a buy rating on SKF India with a 12-month target price of Rs 1550. The global investment bank is enthused by the improving top line visibility.The global investment bank draws comfort from the fact that the company has retained benefits of commodity deflation. CLSA prefer Ambuja over ACC due to greater savings potential and past commitments of stake increases. Post the deal, LafargeHolcim is likely to own 60 per cent in Ambuja.

Source: Economic Times July 21, 2016 05:47 UTC